Business NewsPR NewsWire • Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)

Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)

Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)

BEIJING, Oct 24 /PRNewswire-Asia-FirstCall/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that Sinovac Biotech (Hong Kong) Ltd., its wholly owned subsidiary company in Hong Kong, has received the Certificate of Drug/Product Registra

View More : http://www.prnewswire.com/news-releases/sinovac-receives-drug-registration-certificate-from-hong-kong-department-of-heal...
Releted News by prnewswire
2011 Ram Laramie Longhorn Named 'Truck of Texas'
Wilson Sonsini Goodrich & Rosati Opens Hong Kong Office
VocaLink Research Shows a Demand for a New Mobile Payments Proposition
Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)